Showing results (471-480 of 3,070) with videos related to
Sort By:
Pageof 307
Pharmacological Reports : PR|February 29, 2016
Effect of resveratrol on the pharmacokinetics of fexofenadine in rats: Involvement of P-glycoprotein inhibitionSatish Kumar Bedada, Narsimha Reddy Yellu, Prasad NeeratiPharmacological Reports : PR|February 29, 2016
Hesperidin alleviates cisplatin-induced hepatotoxicity in rats without inhibiting its antitumor activityHany A Omar, Wafaa R Mohamed, El-Shaimaa A Arafa, et al.Pharmacological Reports : PR|February 29, 2016
The influence of aripiprazole and olanzapine on the anxiolytic-like effect observed in prenatally stressed rats (animal model of schizophrenia) exposed to the ethyl alcoholPiotr Ratajczak, Krzysztof Kus, Wojciech Giermaziak, et al.Pharmacological Reports : PR|February 29, 2016
The effect of metformin on the hypothalamic-pituitary-thyroid axis in patients with type 2 diabetes and amiodarone-induced hypothyroidismRobert Krysiak, Małgorzata Gilowska, Witold Szkróbka, et al.Pharmacological Reports : PR|September 1, 2015
The role of ecto-5'-nucleotidase in endothelial dysfunction and vascular pathologiesPaulina Zukowska, Barbara Kutryb-Zajac, Marta Toczek, et al.Pharmacological Reports : PR|September 1, 2015
Liver sinusoidal endothelial cells (LSECs) function and NAFLD; NO-based therapy targeted to the liverEdyta Maslak, Aleksandra Gregorius, Stefan ChlopickiPharmacological Reports : PR|September 1, 2015
Perspectives for angiotensin profiling with liquid chromatography/mass spectrometry to evaluate ACE/ACE2 balance in endothelial dysfunction and vascular pathologiesMariola Olkowicz, Stefan Chlopicki, Ryszard T SmolenskiPharmacological Reports : PR|September 1, 2015
Comprehensive assessment of vascular health in patients; towards endothelium-guided therapyMarzena Frolow, Agata Drozdz, Agata Kowalewska, et al.Pharmacological Reports : PR|January 7, 2015
H2S donors attenuate diabetic nephropathy in rats: Modulation of oxidant status and polyol pathwayMarwa M Safar, Rania M AbdelsalamPharmacological Reports : PR|January 7, 2015
HMG-COA reductase inhibitors: An opportunity for the improvement of imatinib safety. An experimental study in rat pulmonary hypertensionMagdalena Jasińska-Stroschein, Jacek Owczarek, Anna Surowiecka, et al.Pageof 307